gvtcx

Sickle Cell and Thalassemia lab clinical support 2027

NHS England Published 26 Aug 2026 Find a Tender

key details

Value£37,715 (£45,258 inc. VAT)
Statuscomplete
Proceduredirect
OCIDocds-h6vhtk-06ec92

Award

SupplierValueDateStatus
Oxford University Hospitals NHS FT · · active

description

Screening clinical service to provide dedicated clinical support for antenatal and newborn haemoglobinopathy screening laboratories, and other healthcare professionals delivering the Sickle Cell and Thalassaemia Programme, ensuring screening services are delivered to a satisfactory clinical standard.

Objectives of the service include:

  • Supporting newborn and antenatal enquiries. This will be in line with National Screening Programme Policy and standards which will involve checking website for changes and updates; latest policies must be adhered to at all times.
  • Telephone and e-mail support for clinical screening staff
  • Liaison with Programme Centre including two meetings per year.
  • Participation in twice yearly workshops

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
26 Aug 2026 Contract details (UK7) Procurement Act 2023 081313-2026

more from NHS England

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.